Sexual symptoms often untreated during breast cancer endocrine therapy
Sexual dysfunction, genital and urinary symptoms were common among people receiving endocrine therapy for breast cancer, a review found.
Sexual dysfunction, genital and urinary symptoms were common among people receiving endocrine therapy for breast cancer, a review found.
Sexual distress remained stable after breast cancer treatment and was linked to demoralization and self-compassion.
Complications after breast-conserving surgery were linked to a 6.45-fold higher risk of delayed adjuvant therapy, a study found.